Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Microsoft
MSFT
|
+$928M |
| 3 |
McDonald's
MCD
|
+$762M |
| 4 |
Amazon
AMZN
|
+$716M |
| 5 |
Coca-Cola
KO
|
+$650M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$1.78B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.22B |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
+$625M |
| 4 |
Kroger
KR
|
+$547M |
| 5 |
Danaher
DHR
|
+$504M |
Sector Composition
| 1 | Technology | 16.69% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 12.79% |
| 4 | Financials | 12.71% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
2601
DELISTED
CARGO Therapeutics
CRGX
| $2.09M | ﹤0.01% |
507,418
+438,312
| +634% | +$1.81M |
|
2602
iShares MSCI Mexico ETF
EWW
$1.93B
| $2.09M | ﹤0.01% |
34,480
+33,767
| +4,736% | +$2.04M |
|
2603
Invesco Water Resources ETF
PHO
$2.21B
| $2.09M | ﹤0.01% |
29,860
-2,843
| -9% | -$199K |
|
|
AZNH
2604
AstraZeneca PLC ADRhedged
AZNH
$4.6M
| $2.09M | ﹤0.01% |
50,911
-28,411
| -36% | -$1.16M |
|
2605
VEON
VEON
$3.64B
| $2.09M | ﹤0.01% |
45,296
-15,824
| -26% | -$729K |
|
2606
Vanguard Small-Cap ETF
VB
$67.5B
| $2.08M | ﹤0.01% |
8,791
-10,666
| -55% | -$2.53M |
|
2607
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$485M
| $2.08M | ﹤0.01% |
23,686
-23,775
| -50% | -$2.09M |
|
2608
American Century Focused Dynamic Growth ETF
FDG
$359M
| $2.08M | ﹤0.01% |
+19,053
| New | +$2.08M |
|
2609
Construction Partners
ROAD
$7.07B
| $2.08M | ﹤0.01% |
19,568
+5,436
| +38% | +$578K |
|
2610
Microvision
MVIS
$355M
| $2.08M | ﹤0.01% |
1,823,566
+1,536,973
| +536% | +$1.75M |
|
2611
Invesco Total Return Bond ETF
GTO
$1.95B
| $2.08M | ﹤0.01% |
44,317
+38,034
| +605% | +$1.78M |
|
2612
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$424M
| $2.08M | ﹤0.01% |
+90,215
| New | +$2.08M |
|
2613
American Express Global Business Travel
GBTG
$4.34B
| $2.08M | ﹤0.01% |
329,663
+63,856
| +24% | +$402K |
|
2614
ImmunityBio
IBRX
$2.61B
| $2.08M | ﹤0.01% |
786,225
+307,902
| +64% | +$813K |
|
2615
ATN International
ATNI
$233M
| $2.07M | ﹤0.01% |
127,661
-27,091
| -18% | -$440K |
|
2616
Vimeo
VMEO
$1.29B
| $2.07M | ﹤0.01% |
512,985
+218,878
| +74% | +$884K |
|
2617
Tyra Biosciences
TYRA
$659M
| $2.07M | ﹤0.01% |
216,136
+119,854
| +124% | +$1.15M |
|
|
MREO
2618
Mereo BioPharma
MREO
$280M
| $2.06M | ﹤0.01% |
760,659
+417,006
| +121% | +$1.13M |
|
2619
Fidelity Value Factor ETF
FVAL
$1.04B
| $2.06M | ﹤0.01% |
32,237
-10,876
| -25% | -$695K |
|
|
BCAX
2620
Bicara Therapeutics Inc. Common Stock
BCAX
$599M
| $2.06M | ﹤0.01% |
+221,516
| New | +$2.06M |
|
2621
FlexShares Ultra-Short Income Fund
RAVI
$1.37B
| $2.05M | ﹤0.01% |
27,152
-51,339
| -65% | -$3.88M |
|
2622
Global X MLP ETF
MLPA
$1.84B
| $2.05M | ﹤0.01% |
40,764
+38,542
| +1,735% | +$1.93M |
|
2623
iShares Russell 2500 ETF
SMMD
$1.69B
| $2.04M | ﹤0.01% |
30,139
+8,206
| +37% | +$556K |
|
2624
B&G Foods
BGS
$363M
| $2.04M | ﹤0.01% |
482,617
+283,183
| +142% | +$1.2M |
|
2625
eXp World Holdings
EXPI
$1.75B
| $2.04M | ﹤0.01% |
224,273
+133,786
| +148% | +$1.22M |
|